Ligand validation:2YXU

ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP is a Ligand Of Interest in 2YXU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YXU_ATP_A_1410	90%	17%	0.094	0.975	2	1.66	9	10	0	0	100%	1
2YXU_ATP_B_2410	88%	15%	0.097	0.971	2.06	1.72	10	7	0	0	100%	1
3KEU_ATP_B_409	87%	30%	0.101	0.972	1.19	1.61	2	7	1	0	100%	1
4EN4_ATP_B_404	85%	30%	0.105	0.972	1.16	1.63	2	9	1	0	100%	1
3FHX_ATP_B_409	82%	27%	0.117	0.973	1.25	1.68	2	8	0	0	100%	1
3FHY_ATP_B_407	82%	31%	0.115	0.969	1.18	1.54	2	5	2	0	100%	1
2PNN_ATP_A_374	100%	30%	0.027	0.995	1.34	1.43	4	5	2	0	100%	0.9774
5J1T_ATP_A_401	100%	31%	0.03	0.994	1.31	1.43	2	7	0	0	100%	1
1XDN_ATP_A_501	100%	45%	0.03	0.99	1	1.14	2	3	0	0	100%	1
3MHY_ATP_C_113	100%	53%	0.034	0.992	0.86	0.94	-	2	0	0	100%	1
4CBU_ATP_A_1369	100%	50%	0.045	0.997	0.68	1.25	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.